How to diagnose cytoplasmic (deoxyribonucleic acid) DNA presence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diagnosing cytoplasmic DNA presence is typically done through methods such as next-generation sequencing, PCR, and DNAse digestion.

Key Methods

  • Next-generation sequencing: to analyze EV-DNA content 1
  • PCR: to validate the EV-DNA content 1
  • DNAse digestion: to demonstrate the presence of intravesicular DNA, a DNAse digestion step of intact EVs is needed 1 These methods are essential in detecting the presence of DNA in extracellular vesicles (EVs), which can differ from DNA found in apoptotic bodies, especially under stress conditions.

Importance of DNAse Digestion

The use of DNAse digestion is crucial as it helps to distinguish between DNA that is truly intravesicular and DNA that may be adhering to the outside of the EVs. By employing these methods, researchers and clinicians can accurately diagnose the presence of cytoplasmic DNA, which is vital for understanding various biological processes and potential disease mechanisms.

From the Research

Detection Methods

  • Fluorescence in situ hybridization (FISH) can be used for the intracellular detection of DNA or RNA molecules, however, RNA FISH can detect cytoplasmic DNA without the need for denaturation 2.
  • Whole-genomic amplification (WGA) can be used to detect DNA in blastocoelic fluid, which can be correlated with embryo ploidy and viable pregnancy 3.

Cytoplasmic DNA Dynamics

  • Autophagy regulates cytoplasmic dsDNA accumulation and subsequent redistribution into extracellular vesicles 4.
  • Accumulated cytoplasmic dsDNAs can activate the STING pathway, reducing leukemia cell viability through reactive oxygen species (ROS) generation 4.
  • STING recognition of cytoplasmic DNA instigates cellular defense, including the activation of innate immune and proinflammatory genes 5.

Implications

  • The presence of DNA in blastocoelic fluid can be correlated with blastocyst ploidy condition and implantation potential 3.
  • Manipulation of cytoplasmic dsDNA dynamics can be a novel and potent therapeutic strategy for myeloid leukemias 4.
  • Cytoplasmic membrane-associated transcription of cytoplasmic DNA can occur through a special transcription system involving DNA-dependent RNA polymerase II 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.